67 FR 132 pg. 45751 - National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting
Type: NOTICEVolume: 67Number: 132Page: 45751
FR document: [FR Doc. 02-17230 Filed 7-9-02; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: National Institutes of Health
Official PDF Version: PDF Version
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Arthritis and Musculoskeletal and Skin Diseases Special Emphasis Panel. Contract-RFP-NIH-NIAMS-BAA-02-05 Pilot and Feasibility Trials for Osteoporosis.
Date: July 10, 2002.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate contract proposals.
Place: Double Tree Hotel, 1750 Rockville Pike, Rockville, MD 20853.
Contact Person: Tracy A. Shahan, PhD, Scientific Review Administrator, National Institute of Arthritis and, Musculoskeletal and Skin Diseases, Natcher Building, MSC 6500, 45 Center Drive, 5AS-25H, Bethesda, MD 20892, (301) 594-4952.
This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.846, Arthritis, Musculoskeletal and Skin Diseases Research, National Institute of Health, HHS)
Dated: July 2, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-17230 Filed 7-9-02; 8:45 am]
BILLING CODE 4140-01-M